Bhaskar Chaudhuri's most recent trade in Tarsus Pharmaceuticals Inc was a trade of 3,837 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 25, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tarsus Pharma Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 3,837 | 3,837 | - | - | Stock Option (right to buy) | |
| Tarsus Pharma Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2026 | 2,417 | 2,417 | - | - | Restricted Stock Units | |
| Tarsus Pharma Inc | Bhaskar Chaudhuri | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2026 | 2,954 | 0 | - | - | Restricted Stock Units | |
| Tarsus Pharma Inc | Bhaskar Chaudhuri | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2026 | 2,954 | 11,654 | - | - | Common Stock | |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 20,568 | 20,568 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 7,609 | 867,826 (2%) | 0% | 0 | Common Stock | |
| Tarsus Pharma Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 4,540 | 4,540 | - | - | Stock Option (right to buy) | |
| Tarsus Pharma Inc | Bhaskar Chaudhuri | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 3,350 | 0 | - | - | Restricted Stock Units | |
| Tarsus Pharma Inc | Bhaskar Chaudhuri | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 3,350 | 8,700 | - | - | Common Stock | |
| Tarsus Pharma Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 2,954 | 2,954 | - | - | Restricted Stock Units | |
| Tarsus Pharma Inc | Bhaskar Chaudhuri | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2024 | 3,350 | 5,350 | - | - | Common Stock | |
| Tarsus Pharma Inc | Bhaskar Chaudhuri | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2024 | 3,350 | 0 | - | - | Restricted Stock Units | |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | 14 Jun 2024 | 27,052 | 27,052 | - | - | Stock Option (right to buy) | ||
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | 14 Jun 2024 | 10,139 | 860,217 (2%) | 0% | 0 | Common Stock | ||
| Tarsus Pharma Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Tarsus Pharma Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 3,350 | 3,350 | - | - | Restricted Stock Units | |
| Tarsus Pharma Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Tarsus Pharma Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 3,350 | 3,350 | - | - | Restricted Stock Units | |
| Tarsus Pharma Inc | Bhaskar Chaudhuri | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 2,000 | 0 | - | - | Restricted Stock Units | |
| Tarsus Pharma Inc | Bhaskar Chaudhuri | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 2,000 | 2,000 | - | - | Common Stock | |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | 31 May 2023 | 12,220 | 12,220 | - | - | Stock Option (right to buy) | ||
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | 31 May 2023 | 4,375 | 850,078 (2%) | 0% | 0 | Common Stock | ||
| Tarsus Pharma Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 7,000 | 7,000 | - | - | Stock Option (right to buy) | |
| Tarsus Pharma Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 2,000 | 2,000 | - | - | Restricted Stock Units | |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 11,796 | 11,796 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Bhaskar Chaudhuri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 4,312 | 845,703 (2%) | 0% | 0 | Common Stock |